Selective activation of the wnt-signaling pathway as a novel therapy for the treatment of diabetic retinopathy and other retinal vascular diseases

HIGHLIGHTS

• who: Huy Nguyen and collaborators from the Surrozen Operating, Inc, Oyster Point Blvd, Suite, South San Francisco, CA, USA have published the research: Selective Activation of the Wnt-Signaling Pathway as a Novel Therapy for the Treatment of Diabetic Retinopathy and Other Retinal Vascular Diseases, in the Journal: Pharmaceutics 2022, 14, 2476. of /2022/
• what: The authors provide perspective on a new therapeutic strategy that selectively activates the Wnt/u03b2-catenin signaling pathway in retinal endothelial cells as a potential therapy for DR and other retinal vascular diseases.
• how: The combination of reducing . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.